brimonidine tartrate has been researched along with Diabetes Mellitus, Type 2 in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 5 (62.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aldington, SJ; Bandello, F; Costa, MÂ; Cunha-Vaz, J; Egan, C; Frydkjaer-Olsen, U; García-Arumí, J; Gibson, J; Grauslund, J; Harding, SP; Hernández, C; Lang, GE; Lattanzio, R; Lobo, C; Massin, P; Midena, E; Ponsati, B; Porta, M; Ribeiro, L; Scanlon, P; Simó, R | 1 |
| Cunha-Vaz, J; Fernández-Carneado, J; Frydkjaer-Olsen, U; Grauslund, J; Hernández, C; Peto, T; Ponsati, B; Simó, R | 1 |
| Lugo, E; Méndez-Cepeda, P; Sevillano, C; Viso, E | 1 |
| Cunha-Vaz, J; Frydkjaer-Olsen, U; Grauslund, J; Peto, T; Simó, R; Soegaard Hansen, R | 1 |
| Adorjan, I; Bauer, L; Belz, M; Brunmair, B; de Cillia, VA; Fenzl, A; Frobel, K; Fürnsinn, C; Gruber, D; Lehner, Z; Luger, A; Rustenbeck, I; Stadlbauer, K | 1 |
| Baidya, KP; Bhaduri, G; Bhattacharya, B; Chatterjee, PR; Mondal, LK | 1 |
| Burgdorf, C; Dendorfer, A; Kurz, T; Richardt, G; Schütte, F | 1 |
| Kamata, K; Kobayashi, T; Matsumoto, T | 1 |
4 trial(s) available for brimonidine tartrate and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Effects of Topically Administered Neuroprotective Drugs in Early Stages of Diabetic Retinopathy: Results of the EUROCONDOR Clinical Trial.
Topics: Administration, Topical; Aged; Brimonidine Tartrate; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Humans; Middle Aged; Neuroprotective Agents; Somatostatin | 2019 |
Topical Treatment With Brimonidine and Somatostatin Causes Retinal Vascular Dilation in Patients With Early Diabetic Retinopathy From the EUROCONDOR.
Topics: Adrenergic alpha-2 Receptor Agonists; Adult; Aged; Brimonidine Tartrate; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Female; Humans; Male; Middle Aged; Neuroprotective Agents; Prospective Studies; Retinal Vessels; Somatostatin | 2019 |
Correlation between Retinal Vessel Calibre and Neurodegeneration in Patients with Type 2 Diabetes Mellitus in the European Consortium for the Early Treatment of Diabetic Retinopathy (EUROCONDOR).
Topics: Adrenergic alpha-2 Receptor Agonists; Aged; Brimonidine Tartrate; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Drug Therapy, Combination; Electroretinography; Female; Follow-Up Studies; Hormones; Humans; Jupiter; Male; Middle Aged; Neuroprotective Agents; Ophthalmic Solutions; Prospective Studies; Retinal Degeneration; Retinal Ganglion Cells; Retinal Vessels; Somatostatin; Time Factors; Tomography, Optical Coherence; Treatment Outcome | 2016 |
The efficacy of topical administration of brimonidine to reduce ischaemia in the very early stage of diabetic retinopathy in good controlled type-2 diabetes mellitus.
Topics: Aneurysm; Antihypertensive Agents; Blood Glucose; Brimonidine Tartrate; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Humans; Ischemia; Middle Aged; Prospective Studies; Quinoxalines; Time Factors; Treatment Outcome; Vision, Ocular | 2004 |
4 other study(ies) available for brimonidine tartrate and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
[Iris microhaemangiomas: presentation of a case].
Topics: Administration, Topical; Aged; Brimonidine Tartrate; Cyclopentolate; Dexamethasone; Diabetes Mellitus, Type 2; Female; Glaucoma, Open-Angle; Hamartoma; Humans; Hyphema; Iris Diseases; Latanoprost; Microscopy, Acoustic; Ophthalmic Solutions; Prostaglandins F, Synthetic; Quinoxalines; Vision Disorders | 2014 |
Mechanisms of antihyperglycaemic action of efaroxan in mice: time for reappraisal of α2A-adrenergic antagonism in the treatment of type 2 diabetes?
Topics: Adrenergic alpha-2 Receptor Antagonists; Adrenergic alpha-Antagonists; Animals; Antihypertensive Agents; Benzofurans; Brimonidine Tartrate; Calcium; Cells, Cultured; Diabetes Mellitus, Type 2; Diazoxide; Female; Hyperglycemia; Imidazoles; Insulin; Insulin-Secreting Cells; KATP Channels; Male; Membrane Potentials; Mice; Mice, Inbred C57BL; Patch-Clamp Techniques; Quinoxalines; Yohimbine | 2012 |
Impairment of presynaptic alpha2-adrenoceptor-regulated norepinephrine overflow in failing hearts from Zucker diabetic fatty rats.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Blood Glucose; Body Weight; Brimonidine Tartrate; Diabetes Mellitus, Type 2; Electric Stimulation; Heart Failure; Heterozygote; Homozygote; Male; Norepinephrine; Organ Size; Perfusion; Quinoxalines; Rats; Rats, Zucker; Receptors, Adrenergic, alpha-2; Receptors, Presynaptic; Yohimbine | 2006 |
Mechanisms underlying lysophosphatidylcholine-induced potentiation of vascular contractions in the Otsuka Long-Evans Tokushima Fatty (OLETF) rat aorta.
Topics: Animals; Aorta, Thoracic; Brimonidine Tartrate; Diabetes Mellitus, Type 2; Disease Models, Animal; Dose-Response Relationship, Drug; Lysophosphatidylcholines; Male; MAP Kinase Signaling System; Muscle, Smooth, Vascular; Potassium; Protein Kinase Inhibitors; Protein Tyrosine Phosphatases; Quinoxalines; Rats; Rats, Inbred OLETF; Rats, Long-Evans; Receptors, G-Protein-Coupled; RNA, Messenger; Up-Regulation; Vanadates; Vasoconstriction; Vasoconstrictor Agents | 2006 |